These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28830448)

  • 1. Significant decrease of saturation index in erythrocytes membrane from subjects with non-alcoholic fatty liver disease (NAFLD).
    Notarnicola M; Caruso MG; Tutino V; Bonfiglio C; Cozzolongo R; Giannuzzi V; De Nunzio V; De Leonardis G; Abbrescia DI; Franco I; Intini V; Mirizzi A; Osella AR
    Lipids Health Dis; 2017 Aug; 16(1):160. PubMed ID: 28830448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes of the Fatty Acid Profile in Erythrocyte Membranes of Patients following 6-Month Dietary Intervention Aimed at the Regression of Nonalcoholic Fatty Liver Disease (NAFLD).
    Maciejewska D; Marlicz W; Ryterska K; Banaszczak M; Jamioł-Milc D; Stachowska E
    Can J Gastroenterol Hepatol; 2018; 2018():5856201. PubMed ID: 30631760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of the Omega-3 Index in predicting non-alcoholic fatty liver disease in overweight and obese adults: a pilot study.
    Parker HM; O'Connor HT; Keating SE; Cohn JS; Garg ML; Caterson ID; George J; Johnson NA
    Br J Nutr; 2015 Sep; 114(5):780-7. PubMed ID: 26202539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced Liver Fibrosis Is Independently Associated with Palmitic Acid and Insulin Levels in Patients with Non-Alcoholic Fatty Liver Disease.
    Cansanção K; Silva Monteiro L; Carvalho Leite N; Dávalos A; Tavares do Carmo MDG; Arantes Ferreira Peres W
    Nutrients; 2018 Oct; 10(11):. PubMed ID: 30380656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrocyte membrane fatty acid profile & serum cytokine levels in patients with non-alcoholic fatty liver disease.
    Amirkalali B; Sohrabi MR; Esrafily A; Jalali M; Gholami A; Hosseinzadeh P; Keyvani H; Shidfar F; Zamani F
    Indian J Med Res; 2018 Apr; 147(4):352-360. PubMed ID: 29998870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.
    Ampuero J; Ranchal I; Gallego-Durán R; Pareja MJ; Del Campo JA; Pastor-Ramírez H; Rico MC; Picón R; Pastor L; García-Monzón C; Andrade R; Romero-Gómez M
    J Gastroenterol Hepatol; 2016 Sep; 31(9):1611-8. PubMed ID: 26946071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemoglobin combined with triglyceride and ferritin in predicting non-alcoholic fatty liver.
    Jiang Y; Zeng J; Chen B
    J Gastroenterol Hepatol; 2014; 29(7):1508-14. PubMed ID: 24628002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different Serum Free Fatty Acid Profiles in NAFLD Subjects and Healthy Controls after Oral Fat Load.
    Gambino R; Bugianesi E; Rosso C; Mezzabotta L; Pinach S; Alemanno N; Saba F; Cassader M
    Int J Mol Sci; 2016 Mar; 17(4):479. PubMed ID: 27043543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a 6-month dietary-induced weight loss on erythrocyte membrane omega-3 fatty acids and hepatic status of subjects with nonalcoholic fatty liver disease: The Fatty Liver in Obesity study.
    Marin-Alejandre BA; Abete I; Monreal JI; Elorz M; Benito-Boillos A; Herrero JI; Navarro-Blasco I; Tur JA; Bandarra NM; Zulet MA; Martinez JA
    J Clin Lipidol; 2020; 14(6):837-849.e2. PubMed ID: 32962964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory parameters in lean NAFLD: comparison of subjects with lean NAFLD with obese subjects without hepatic steatosis.
    Bernhardt P; Kratzer W; Schmidberger J; Graeter T; Gruener B;
    BMC Res Notes; 2018 Feb; 11(1):101. PubMed ID: 29409538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternation of plasma fatty acids composition and desaturase activities in children with liver steatosis.
    Hua MC; Su HM; Yao TC; Kuo ML; Lai MW; Tsai MH; Huang JL
    PLoS One; 2017; 12(7):e0182277. PubMed ID: 28759573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dietary fatty acids and cholesterol excess on liver injury: A lipidomic approach.
    Serviddio G; Bellanti F; Villani R; Tamborra R; Zerbinati C; Blonda M; Ciacciarelli M; Poli G; Vendemiale G; Iuliano L
    Redox Biol; 2016 Oct; 9():296-305. PubMed ID: 27639112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid profile changes in erythrocyte membranes of women with diagnosed GDM.
    Bukowiecka-Matusiak M; Burzynska-Pedziwiatr I; Sansone A; Malachowska B; Zurawska-Klis M; Ferreri C; Chatgilialoglu C; Ochedalski T; Cypryk K; Wozniak LA
    PLoS One; 2018; 13(9):e0203799. PubMed ID: 30216387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case-control study on nutritional risk factors in non-alcoholic fatty liver disease in Indian population.
    Sathiaraj E; Chutke M; Reddy MY; Pratap N; Rao PN; Reddy DN; Raghunath M
    Eur J Clin Nutr; 2011 Apr; 65(4):533-7. PubMed ID: 21346716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interplay between Oxidative Stress and Metabolic Derangements in Non-Alcoholic Fatty Liver Disease: The Role of Selenoprotein P.
    Caviglia GP; Rosso C; Armandi A; Gaggini M; Carli F; Abate ML; Olivero A; Ribaldone DG; Saracco GM; Gastaldelli A; Bugianesi E
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33266488
    [No Abstract]   [Full Text] [Related]  

  • 17. Non-alcoholic fatty liver disease is characterised by a reduced polyunsaturated fatty acid transport via free fatty acids and high-density lipoproteins (HDL).
    Mocciaro G; Allison M; Jenkins B; Azzu V; Huang-Doran I; Herrera-Marcos LV; Hall Z; Murgia A; Susan D; Frontini M; Vidal-Puig A; Koulman A; Griffin JL; Vacca M
    Mol Metab; 2023 Jul; 73():101728. PubMed ID: 37084865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum phospholipid omega-3 polyunsaturated fatty acids and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease.
    Lou DJ; Zhu QQ; Si XW; Guan LL; You QY; Yu ZM; Zhang AZ
    J Diabetes Complications; 2014; 28(5):711-4. PubMed ID: 24927647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced circulating levels of sTWEAK are associated with NAFLD and may affect hepatocyte triglyceride accumulation.
    Lozano-Bartolomé J; Llauradó G; Rodriguez MM; Fernandez-Real JM; Garcia-Fontgivell JF; Puig J; Maymó-Masip E; Vendrell J; Chacón MR
    Int J Obes (Lond); 2016 Sep; 40(9):1337-45. PubMed ID: 27121253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic fatty liver disease severity is associated with the ratios of total cholesterol and triglycerides to high-density lipoprotein cholesterol.
    Wu KT; Kuo PL; Su SB; Chen YY; Yeh ML; Huang CI; Yang JF; Lin CI; Hsieh MH; Hsieh MY; Huang CF; Lin WY; Yu ML; Dai CY; Wang HY
    J Clin Lipidol; 2016; 10(2):420-5.e1. PubMed ID: 27055973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.